BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33746892)

  • 41. Extent and distribution of white matter hyperintensities in stroke patients: the Sydney Stroke Study.
    Wen W; Sachdev PS
    Stroke; 2004 Dec; 35(12):2813-9. PubMed ID: 15499036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
    Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
    Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational quantification of brain perivascular space morphologies: Associations with vascular risk factors and white matter hyperintensities. A study in the Lothian Birth Cohort 1936.
    Ballerini L; Booth T; Valdés Hernández MDC; Wiseman S; Lovreglio R; Muñoz Maniega S; Morris Z; Pattie A; Corley J; Gow A; Bastin ME; Deary IJ; Wardlaw J
    Neuroimage Clin; 2020; 25():102120. PubMed ID: 31887717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients.
    Yu L; Yang L; Li Y; Yang S; Gu H; Hu W; Gao S
    Int J Neurosci; 2020 Mar; 130(3):231-236. PubMed ID: 31744348
    [No Abstract]   [Full Text] [Related]  

  • 45. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
    Xiong Y; Wong A; Cavalieri M; Schmidt R; Chu WW; Liu X; Wong KS; Mok V
    Neurotherapeutics; 2014 Jul; 11(3):606-11. PubMed ID: 24692001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: A multicenter study in 1568 stroke patients.
    Coenen M; de Kort FA; Weaver NA; Kuijf HJ; Aben HP; Bae HJ; Bordet R; Chen CP; Dewenter A; Doeven T; Dondaine T; Duering M; Fang R; van der Giessen RS; Kim J; Kim BJ; de Kort PL; Koudstaal PJ; Lee M; Lim JS; Lopes R; van Oostenbrugge RJ; Staals J; Yu KH; Biessels GJ; Biesbroek JM
    Int J Stroke; 2024 Jun; ():17474930241252530. PubMed ID: 38651756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.
    Rudilosso S; Stringer MS; Thrippleton M; Chappell F; Blair GW; Jaime Garcia D; Doubal F; Hamilton I; Janssen E; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; Duering M; Dichgans M; Wardlaw JM;
    J Cereb Blood Flow Metab; 2023 Sep; 43(9):1490-1502. PubMed ID: 37132279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies.
    de Kort FAS; Coenen M; Weaver NA; Kuijf HJ; Aben HP; Bae HJ; Bordet R; Cammà G; Chen CPLH; Dewenter A; Duering M; Fang R; van der Giessen RS; Hamilton OKL; Hilal S; Huenges Wajer IMC; Kan CN; Kim J; Kim BJ; Köhler S; de Kort PLM; Koudstaal PJ; Lim JS; Lopes R; Mok VCT; Staals J; Venketasubramanian N; Verhagen CM; Verhey FRJ; Wardlaw JM; Xu X; Yu KH; Biesbroek JM; Biessels GJ
    Stroke; 2023 Dec; 54(12):3021-3029. PubMed ID: 37901947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease.
    Wiseman SJ; Doubal FN; Chappell FM; Valdés-Hernández MC; Wang X; Rumley A; Lowe GD; Dennis MS; Wardlaw JM
    Cerebrovasc Dis; 2015; 40(3-4):157-64. PubMed ID: 26279056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
    Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
    Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variation in risk factors for recent small subcortical infarcts with infarct size, shape, and location.
    Del Bene A; Makin SD; Doubal FN; Inzitari D; Wardlaw JM
    Stroke; 2013 Nov; 44(11):3000-6. PubMed ID: 24008573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum neurofilament light is sensitive to active cerebral small vessel disease.
    Gattringer T; Pinter D; Enzinger C; Seifert-Held T; Kneihsl M; Fandler S; Pichler A; Barro C; Gröbke S; Voortman M; Pirpamer L; Hofer E; Ropele S; Schmidt R; Kuhle J; Fazekas F; Khalil M
    Neurology; 2017 Nov; 89(20):2108-2114. PubMed ID: 29046363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Counting cavitating lacunes underestimates the burden of lacunar infarction.
    Potter GM; Doubal FN; Jackson CA; Chappell FM; Sudlow CL; Dennis MS; Wardlaw JM
    Stroke; 2010 Feb; 41(2):267-72. PubMed ID: 20044528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL.
    Duering M; Zieren N; Hervé D; Jouvent E; Reyes S; Peters N; Pachai C; Opherk C; Chabriat H; Dichgans M
    Brain; 2011 Aug; 134(Pt 8):2366-75. PubMed ID: 21764819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study.
    Viswanathan A; Guichard JP; Gschwendtner A; Buffon F; Cumurcuic R; Boutron C; Vicaut E; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
    Brain; 2006 Sep; 129(Pt 9):2375-83. PubMed ID: 16844717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive impact of lacunar infarcts and white matter hyperintensity volume.
    Warren MW; Weiner MF; Rossetti HC; McColl R; Peshock R; King KS
    Dement Geriatr Cogn Dis Extra; 2015; 5(1):170-5. PubMed ID: 26034488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum Uric Acid Is Associated with Cerebral White Matter Hyperintensities in Patients with Acute Lacunar Infarction.
    Han SW; Song TJ; Bushnell CD; Lee SS; Kim SH; Lee JH; Kim GS; Kim OJ; Koh IS; Lee JY; Suk SH; Lee SI; Nam HS; Lee KY; Park JH
    J Neuroimaging; 2016 May; 26(3):351-4. PubMed ID: 26458336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
    J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.